You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 272 No. 4, July 27, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Proposal to Develop Meaningful Labeling for Cigarettes

Jack E. Henningfield, PhD; Lynn T. Kozlowski, PhD; Neal L. Benowitz, MD

JAMA. 1994;272(4):312-314.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SINCE the 1980s, tobacco researchers have understood that the advertised nicotine-yield ratings of cigarettes do not accurately predict nicotine intake by individual cigarette smokers.1-5 Cigarette smokers obtain an average of 1 mg of nicotine from each cigarette they smoke, whether the nicotine yield is 0.1 mg or 2 mg.4,6 However, smokers with whom we have spoken believe that their "light" or "ultralight" cigarettes are providing them with substantially lower doses of nicotine and other constituents of tobacco smoke. These smokers seem to assume that nicotine-yield ratings are equivalent to the content ratings provided on food products, and they are often distressed to learn that nicotine-yield ratings are not indicative of how much nicotine they can obtain.

We propose a new strategy for testing and labeling cigarettes that would provide consumers with improved information about how much nicotine they will absorb by smoking a particular brand of cigarette. Our . . . [Full Text PDF of this Article]


Author Affiliations

From the Clinical Pharmacology Branch, Addiction Research Center, National Institute on Drug Abuse, Baltimore, Md (Dr Henningfleld); the Program in Biobehavioral Health, College of Health and Human Development, Pennsylvania State University, University Park (Dr Kozlowski); and the Division of Clinical Pharmacology and Experimental Therapeutics and the Departments of Medicine and Psychiatry, University of California—San Francisco (Dr Benowitz).


Footnotes

The views expressed in this article are those of the authors and do not reflect an official position of the federal government or its agencies.

Reprint requests to NIDA Addiction Research Center, PO Box 5180, Baltimore, MD 21224 (Dr Henningfield).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.